Related Experiment Videos
A sebotrophic stimulus in benign and malignant breast disease
Lancet (London, England)
|February 22, 1975
Summary
Increased sebum excretion rates are linked to benign and malignant breast disease. This suggests a potential hormonal connection that could be influenced by certain medications, possibly provoking breast conditions.
Area of Science:
- Endocrinology
- Dermatology
- Oncology
Background:
- The sebum-excretion rate (S.E.R.) is a physiological measure of sebaceous gland activity.
- Previous research has indicated potential links between hormonal factors and breast conditions.
Purpose of the Study:
- To investigate the relationship between sebum-excretion rate (S.E.R.) and breast disease.
- To explore the potential role of sebotrophic hormones in mammogenesis and breast pathology.
Main Methods:
- Measurement of sebum-excretion rate (S.E.R.) in patients.
- Comparison of S.E.R. in patients with benign and malignant breast disease versus control groups.
Main Results:
- Elevated S.E.R. was observed in patients with both benign and malignant breast disease.
- No significant increase in S.E.R. was found in patients undergoing surgery for non-breast related conditions.
Conclusions:
- The sebotrophic hormone may possess mammotrophic properties, suggesting a shared hormonal pathway.
- Medications known to increase sebum production, like reserpine and phenothiazines, might potentially trigger benign or malignant breast disease.